ASCAT-EHA-BSH Sickle Cell Disease Conference 2022
EHA joined forces with the British Society of Haematology (BSH) & Annual Academy of Sickle Cell and Thalassaemia Conference (ASCAT) in organizing the 3rd Sickle Cell & Thalassaemia Conference (the 17th Annual Sickle Cell & Thalassaemia Conference).
Dates: October 20-22, 2022
Location: London, United Kingdom
Format: Physical only
The Annual Scientific Conference on Sickle Cell and Thalassaemia (ASCAT) focuses on promoting the latest advances in diagnosis, treatment, and emerging fields in hemoglobinopathies. It is an opportunity to interact with peers on the latest advances in clinical care, transition services, and emerging new therapies including updates for curative treatment options.
Abstract submission
Abstract submission is an important part of this meeting. As a participant, you will have the opportunity to submit an abstract for this meeting, and (if accepted) have the possibility to discuss it with the international faculty and your peers as an oral presentation or poster. All the accepted abstracts will also be published in the Abstract Book, as an official supplement of HemaSphere.
Please select the most appropriate topic during the abstract & case submission:
-
Basic and translational
-
Novel therapies, gene therapies and bone marrow transplant
-
Artificial intelligence, deep learning and other technological advancements in hemoglobinopathies
-
Clinical, public health and epidemiological studies
-
Clinical, infection and nutritional deficiencies
-
Ageing and end organ damage
-
Health services and outcomes research including psychology
Abstract submission is closed
| Date | Deadline |
| July 1, 2022 | Start abstract & case submission |
| September 9, 2022 | Deadline abstract & case submission |
| September 23, 2022 | Notification of allocation to authors |
For any questions regarding the abstract submission process, please contact scientificmeetings@ehaweb.org.
Target audience
Consultant Hematologists, Pediatricians, Specialist Nurses, Psychologists, Scientists, Fellows and trainees in all related fields
Venue
The meeting will take place Park Plaza, Westminister, London, United Kingdom.
For more information, click here.
Registration
The registration is closed.
For more information, click here.
Program
The program can be found here.
EHA Topics-in-Focus Hemoglobinopathies
This meeting is part of the EHA Topics-in-Focus (TIF) program on Hemoglobinopathies, aimed at raising awareness, providing education, furthering research, and building a network of experts to improve patient care. Further information, please see our website.
EBAH CME accreditation
This meeting is accredited by the European Board for Accreditation in Hematology (EBAH) CME. EBAH CME is the best way for hematologists to master the latest developments within the specialty of hematology. Staying abreast of these scientific developments and keeping in touch with the up-to-date views on clinical policy will enable you to raise your professional level, ultimately resulting in the best treatment for your patients.
Back